News for Invitae Corporation (NVTA.MX)

Published at

Oct 14, 2024 3:00 PM

by globenewswire.com

mixed

mixed

Nanomedicine Market to Hit USD 634.2 Billion by 2032; Improvements in Drug Delivery and Therapeutics Witness Rising Momentum

With rising chronic disease rates and increasing collaboration between pharmaceutical companies and academia, the nanomedicine market is poised for...

PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE JNJ DJNJ3.BA DJNJ2.BA UCBN.MX UCBJY UCBJF UCB.BR NVTA.MX NVTA MRKD.BA MRK.SN MRK.PA MRK.MX MRK DSRLF DIA.MI ARWR ABTCL.SN ABT.SN ABT 6MK.DE 0JDB.L 0HI3.L

Read more →
Published at

Aug 13, 2024 4:00 PM

by globenewswire.com

positive

positive

Press release Biocartis NV: Biocartis appoints renowned

PRESS RELEASE - 13/08/2024, 16:00 CEST Biocartis appoints renowned precision oncology expert, Dr. W. Michael Korn, as Chief Medical and Scientific Officer...

NVTA.MX NVTA 0JDB.L

Read more →
Published at

Aug 3, 2024 7:05 AM

by gurufocus.com

positive

positive

Decoding Labcorp Holdings Inc (LH): A Strategic SWOT Insight

Labcorp's expansive test portfolio and recent acquisitions bolster its market position.Legal challenges and regulatory scrutiny pose potential risks to operati

NVTA.MX NVTA 0JDB.L

Read more →
Published at

Jul 2, 2024 1:24 AM

by insidermonkey.com

neutral

neutral

Invitae Corporation (NVTAQ): A Good Stock to Buy and Hold According to Cathie Wood?

We recently compiled a list of the 10 Best Stocks to Buy and Hold For 5 Years According to Cathie Wood.

NVTA.MX NVTA NVDA 0JDB.L

Read more →
Published at

May 26, 2024 8:00 PM

by globenewswire.com

mixed

mixed

Global Precision Oncology Market Size To Exceed USA 260.5 Billion By 2033 | CAGR Of 10.21%

The Global Precision Oncology Market Size was Valued at USD 98.5 Billion in 2023 and the Worldwide Precision Oncology Market Size is Expected to Reach USD...

TMO.MX TMO NVTA.MX NVTA NVSN.MX NVSEF NVSD.BA NVS NOVN.SW N1VS34.SA ILU.DE ILMN.MX ILMN I1LM34.SA ERAS 0R0H.L 0K9E.L 0JDB.L 0J8Z.L QIAN.MX QIA.DE QGEN

Read more →
Published at

May 23, 2024 11:20 PM

by investing.com

neutral

neutral

New Research Demonstrates the Importance of Genetic Testing for Many Cancers Not Currently Covered by Clinical Guidelines By Investing.com

New Research Demonstrates the Importance of Genetic Testing for Many Cancers Not Currently Covered by Clinical Guidelines

NVTA.MX NVTA 0JDB.L

Read more →
Published at

Apr 25, 2024 3:32 AM

by investing.com

mixed

mixed

Labcorp to acquire Invitae assets for $239 million By Investing.com

Labcorp to acquire Invitae assets for $239 million

NVTA.MX NVTA 0JDB.L FCN

Read more →
Published at

Apr 25, 2024 3:21 AM

by marketscreener.com

mixed

mixed

Invitae Enters into Agreement with Labcorp for Sale of Business

– Labcorp Selected as Winning Bidder in Court-Supervised Sale Process, Subject to Court and Regulatory Approvals – – $239 Million Cash Bid Includes Acquisition of Substantially All of the...

NVTA.MX NVTA 0JDB.L MC FCN

Read more →
Published at

Apr 2, 2024 8:00 PM

by globenewswire.com

neutral

neutral

[Latest] Global Hereditary Cancer Testing Market Size/Share Worth USD 12.1 Billion by 2033 at a 7.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, G

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Hereditary Cancer...

TMO.MX TMO QIAN.MX QIA.DE QGEN NVTA.MX NVTA NTRA MYGN MYD.DE ILU.DE ILMN.MX ILMN I1LM34.SA FMI 0R0H.L 0K3W.L 0JDB.L 0J8Z.L

Read more →
Published at

Feb 15, 2024 8:11 PM

by investing.com

mixed

mixed

Invitae gets court approval for five-month bankruptcy sale By Reuters

Invitae gets court approval for five-month bankruptcy sale

SOBKY SFTBY SFTBF SFBQF NVTA.MX NVTA 0JDB.L

Read more →
Published at

Nov 7, 2023 8:49 AM

by globenewswire.com

mixed

mixed

Genomic Cancer Testing is projected to Hit $45.92 Billion, Globally, by 2030 at 16.1% CAGR: Coherent Market Insights

Genomic cancer testing is a medical diagnostic process that involves analyzing the DNA of cancer cells to identify specific mutations, rearrangements, or...

EXAS TMO.MX TMO QIAN.MX QIA.DE QGEN NVTA.MX NVTA MYGN MYD.DE GH.MX GH FMI BIOC 0R0H.L 0K3W.L 0JDB.L ILU.DE ILMN.MX ILMN I1LM34.SA 0J8Z.L

Read more →
Published at

Oct 23, 2023 4:08 PM

by insidermonkey.com

mixed

mixed

12 Best Penny Stocks to Buy Under $1

Investors are optimistic as we move into the third quarter earnings season.

NVTA.MX NVTA GOSS CMRX AMRN 0JDB.L NKTR KZR CBMG 0UNL.L

Read more →
Published at

Sep 22, 2023 11:15 PM

by prnewswire.com

mixed

mixed

Precision Medicine Takes Center Stage: Innovative Report Explores the Role of Companion Diagnostics in Transforming Healthcare

/PRNewswire/ -- The "Companion Diagnostic Markets - the Future of Diagnostics by Application, Technology and Funding With Executive and Consultant Guides...

CSPHF TXG.MX TXG NH BUWA.DE BIOC BIO-B BIO BDSX ANPCY ANPCF AGL.L ABTCL.SN ABT.SN ABT 0A88.L 064550.KQ TMO.MX TMO NVTA.MX NVTA MLAB LLAI.L EPGNY EPGNF ECX.DE DSRLF DIA.MI CSTL BDXB BDX.MX BDX 300676.SZ 0R19.L 0R0H.L 0JDB.L

Read more →
Published at

Aug 21, 2023 4:27 PM

by globenewswire.com

mixed

mixed

Global Hereditary Genetic Testing Market Size to Reach USD 66.11 Billion in 2030 | Emergen Research

Rising demand for direct-to-consumer genetic testing for developing personalized medicine specifically targeted to individuals is one of the major factors...

NVTA.MX NVTA FLGT.MX FLGT 0JDB.L TMO.MX TMO ILU.DE ILMN.MX ILMN I1LM34.SA DGX.MX DGX 0R0H.L 0KSX.L 0J8Z.L OCLG

Read more →
Published at

Jun 13, 2023 2:39 PM

by globenewswire.com

mixed

mixed

A New Era in Cancer Testing: Clinical Oncology NGS Market

SkyQuest's Clinical Oncology Next Generation Sequencing market report provides actionable insights for individuals interested in valuable data, trends, and...

ERRFY ERFSF ERFNV.PA ERF.PA TMO.MX TMO QIAN.MX QIA.DE QGEN PKI P1KI34.SA NVTA.MX NVTA NTRA MYGN MYD.DE ILU.DE ILMN.MX ILMN I1LM34.SA GNNSF GH.MX GH FMI A1GI34.SA A.MX A 300676.SZ 1548.HK 0R0H.L 0KHE.L 0K3W.L 0JDB.L 0J8Z.L 0HAV.L

Read more →
Published at

Apr 21, 2023 11:17 AM

by prnewswire.com

mixed

mixed

The Global Genetic Analysis Market size is expected to reach $22.31 billion by 2028 | Brandessence Market Research

/PRNewswire/ -- The Global Genetic Analysis Market is poised to amass a valuation of USD 22.31 billion by 2028 from USD 12.57 billion in 2021, registering a...

TMO.MX TMO PKI P1KI34.SA OPK.TA OPK.MX OPK NVTA.MX NVTA 0R0H.L 0KHE.L 0KCS.L 0JDB.L ROSGQ NTRA MYGN MYD.DE LH.MX LH L1CA34.SA ILU.DE ILMN.MX ILMN I1LM34.SA FMI ERRFY ERFSF ERFNV.PA ERF.PA DGX.MX DGX 0KSX.L 0K3W.L 0JSY.L 0J8Z.L

Read more →
Published at

Oct 7, 2022 1:28 PM

by globenewswire.com

mixed

mixed

US Genetic Testing Market Size to Hit USD 10.29 Billion by 2027

According to Fortune Business Insights™, the US Genetic Testing Market size is expected to reach USD 10.29 Billion by 2027, at a CAGR of 13.0% during the...

NVTA.MX NVTA 0JDB.L MYGN MYD.DE BNR 0K3W.L PROG DGX.MX DGX 0KSX.L

Read more →
Published at

Sep 26, 2022 12:15 PM

by prnewswire.com

neutral

neutral

Global Rare Disease Genetic Testing Market to Reach $2.52 Billion by 2030

/PRNewswire/ -- The "Rare Disease Genetic Testing Market Size, Share & Trends Analysis Report by Disease Type (Neurological, CVDs), by Specialty (Molecular,...

PROG OPK.TA OPK.MX OPK NVTA.MX NVTA MYGN MYD.DE LH.MX LH L1CA34.SA FLGT.MX FLGT DGX.MX DGX CNTG 950200.KQ 0KSX.L 0KCS.L 0K3W.L 0JSY.L 0JDB.L

Read more →
Published at

Jun 17, 2022 8:43 AM

by globenewswire.com

mixed

mixed

Nanomedicine Market Size Worth USD 393.04 Billion by 2030 at 9.2% CAGR - Report by Market Research Future (MRFR)

Nanomedicine Market Trends and Insights By Product (Nanoparticles [Metal & Metal Oxide Nanoparticles, Liposomes, Polymers & Polymer-Drug Conjugates,...

TEVJF PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE NSHSF NSHSD NSHS.CN HESG DSRLF DIA.MI NVTA.MX NVTA MRKD.BA MRK.SN MRK.PA MRK.MX MRK JNJ GNE.PA GEC.L GEC.DE GE.SW GE.SN GE.MX GE DJNJ3.BA DJNJ2.BA 6MK.DE 0JDB.L

Read more →
Published at

Jun 6, 2022 11:31 AM

by benzinga.com

mixed

mixed

69 Biggest Movers From Yesterday

Gainers Turning Point Therapeutics, Inc. (NASDAQ: TPTX) shares climbed 118.4% to close at $74.59 on Friday after Bristol Myers Squibb announced it will acquire Turning Point Therapeutics for $76 per share.

ZSAN YMTX WVE VRCA TPTX STNE SRLP RUBY RCMT POAI PBYI OLMA NRIX NINE LOV JWEL IOVA IMTE HARP GRMMD GRMM GRBX GLTO GBOX FORA FIXX EVFM ESGC EFOI DTIL CVGW CURIW CURI CRTX CO BQ BLCM AXDX.MX AXDX AVTX ATTO AEYE ADAP 0T6G.L 0JDK.L 0H8E.L 0A4H.L ZUMZ W.MX W TALK NX NVTA.MX NVTA NVAX.MX NVAX NRXP NMTCD NMTC MRTX MFH KBNTW KBNT IMPHP IMPHO IMH HUSA ACOR 0JDB.L 0A7K.L 0A4A.L 0A3S.L OKTA.MX OKTA O1KT34.SA JOAN 0KB7.L

Read more →